The report by Magellan Rx Management indicates PMPM, site of service, and Medicaid prices continue to increase.
Specialty pharmaceuticals make up a significant part of the current drug market, and their impact is only going to grow over the next few years.
Better care at lower costs is the ultimate goal across healthcare today. Here’s how pharmacists can help.
Stalled competition hurts consumers and may keep prices higher.
Drug Topics recently spoke with the FDA about the role pharmacists can play in patient education.
The annual report on generic access and savings shows some impressive numbers for 2017.
An unclear naming system for biosimilars could affect patient safety.
FDA releases Biosimilar Action Plan
Hurdles to adoption of biosimilars include regulatory issues and lack of interchangeability with the reference drugs.